[PDF] Top 20 FORMULATION AND EVALUATION OF SUSTAINED RELEASE FLOATING TABLET OF ORLISTAT

... In order to evaluate the stability of orlistat in 0.1N HCl solution, 100mg drug was weighed accurately and transferred to 100 ml volumetric flask. Dissolved and volume was made upto mark with 0.1 N HCl solution ... See full document

... be sustained by incorporating an inflatable chamber which contains a liquid ...controlled floating systems containing a hollow deformable unit that can convert from a collapsed to an expanded position and ... See full document

... gastro-retentive sustained release formulation of Loratadine for an effective and safe therapy by using a natural polymer and a synthetic polymer, ...respectively. Floating sustained ... See full document

... the floating tablets prepared contained the drug within 102±5% of the label ...drug release was found for tablets of F8 containing 20% HPMC K15 and HPMC ...drug release rate decreased as the ... See full document

... drug release was calculated. The data obtained from in vitro release for formulations prepared by direct compression technique are tabulated in the Table ...drug release with increase in ... See full document

... muco-adhesive tablet with potential use in the treatment of Type II Diabetes Mellitus, different types and levels of bio-adhesive polymers will be investigated and evaluated for their efficacy in formulating ... See full document

... doses release the entire drug in just few minutes and the therapeutic concentrations are maintained for a short period of time generating a need for administration of another ...a sustained release ... See full document

... work, formulation and evaluation of Sustained tablet of Divalproex sodium was carried ...of sustained release layer have been ...best formulation of each sustained ... See full document

... Ranolazine SR tablets, developed by Kollidon SR, microcrystalline cellulose and magnesium stearate. In which kollidon SR is a polyvinyl acetate based excipient for directly compressible matrix tablets. It required fewer ... See full document

... activity. Floating tablets were prepared by the wet granulation technique by using carbopol as retarding agent and sodium bicarbonate as gas generating ...drug release profile and floating properties ... See full document

... has release profile in range as specified in ...drug release and dissolution profile were not satisfactory in batch C01 to C16 except C07 that having f 2 value ... See full document

... slow release of drug could be due to the formation of uniform coating on individual drug particles by hydrophobic polymer during melt ...drug release retardation from lipophilic binders was in the following ... See full document

... oral sustained controlled release formulation has been ...to release the drug gradually into the gastrointestinal tract to maintain the therapeutic drug concentration in the serum for longer ... See full document

... Metoprolol succinate, β1- selective adrenergic receptor- blocking agent used in the management of hypertension, angina pectoris, cardiac arrthymias, myocardial infarction, heart failure, hyperthyroidism . The half-life ... See full document

... drug release from dosage form in the physiological condition and kinetics of drug ...drug release profiles of F1-F10 are shown in Figure ...drug release in case of poorly soluble ...The ... See full document

... Floating drug delivery system (FDDS) 1 is a novel approach to achieve gastric retention to obtain sufficient drug bioavailability. The gel formed from In situ gelling system, being lighter than gastric fluids, ... See full document

... 2.2.1. Preliminary trial batches : Composition of preliminary trials batches for sustained release formulation is shown in Table II. In all the formulations dose of Lornoxicam 18 mg was taken. ... See full document

... retentive floating matrix tablets of diltiazem ...Ram2,. Formulation and in-vitro evaluation gastroretentive drug delivery system of Cefixime for prolong ... See full document

... years sustained release 5 (SR) dosage forms continue to draw attention in the research for improved patient compliance and decreased incidence of adverse drug ...of sustained release dosage ... See full document

... itself. Sustained release formulation of Acebrophylline can reduce the fluctuation in plasma drug concentration, thus minimizing or preventing plasma peak related adverse event, and allow ... See full document